A citation-based method for searching scientific literature

Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Lilla Reiniger, István Csabai, Francesco Favero, Nicolai J Birkbak, Aron C Eklund, Ali Syed, Zoltan Szallasi. NPJ Breast Cancer 2018
Times Cited: 66



Tatiana Popova, Elodie Manié, Guillaume Rieunier, Virginie Caux-Moncoutier, Carole Tirapo, Thierry Dubois, Olivier Delattre, Brigitte Sigal-Zafrani, Marc Bollet, Michel Longy, Claude Houdayer, Xavier Sastre-Garau, Anne Vincent-Salomon, Dominique Stoppa-Lyonnet, Marc-Henri Stern. Cancer Res 2012
Times Cited: 342




List of shared articles



Times cited


Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
Zsofia Sztupinszki, Miklos Diossy, Judit Borcsok, Aurel Prosz, Nanna Cornelius, Maj K Kjeldsen, Mansoor R Mirza, Zoltan Szallasi. Clin Cancer Res 2021
3

Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population.
Chia-Hsin Wu, Chia-Shan Hsieh, Yo-Cheng Chang, Chi-Cheng Huang, Hsien-Tang Yeh, Ming-Feng Hou, Yuan-Chiang Chung, Shih-Hsin Tu, King-Jen Chang, Amrita Chattopadhyay,[...]. Commun Biol 2021
0

Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.
Judit Börcsök, Miklos Diossy, Zsofia Sztupinszki, Aurel Prosz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Dag R Stormoen, Helle Pappot, Istvan Csabai,[...]. Clin Cancer Res 2021
8

PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, Jacek Jassem. Cancer Treat Rev 2022
1

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Peter Horak, Jonas Leichsenring, Hannah Goldschmid, Simon Kreutzfeldt, Daniel Kazdal, Veronica Teleanu, Volker Endris, Laura Gieldon, Michael Allgäuer, Anna-Lena Volckmar,[...]. Genes Chromosomes Cancer 2022
3

Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families.
Thibaut S Matis, Nadia Zayed, Bouchra Labraki, Manon de Ladurantaye, Théophane A Matis, José Camacho Valenzuela, Nancy Hamel, Adrienne Atayan, Barbara Rivera, Yuval Tabach,[...]. NPJ Breast Cancer 2021
1

ShallowHRD: detection of homologous recombination deficiency from shallow whole genome sequencing.
Alexandre Eeckhoutte, Alexandre Houy, Elodie Manié, Manon Reverdy, Ivan Bièche, Elisabetta Marangoni, Oumou Goundiam, Anne Vincent-Salomon, Dominique Stoppa-Lyonnet, François-Clément Bidard,[...]. Bioinformatics 2020
4

Using whole-genome sequencing data to derive the homologous recombination deficiency scores.
Xavier M de Luca, Felicity Newell, Stephen H Kazakoff, Gunter Hartel, Amy E McCart Reed, Oliver Holmes, Qinying Xu, Scott Wood, Conrad Leonard, John V Pearson,[...]. NPJ Breast Cancer 2020
4

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger,[...]. NPJ Precis Oncol 2021
4

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.
Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher,[...]. J Pathol Clin Res 2022
0

Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response.
Hyeon Gu Kang, Haeun Hwangbo, Myung Ji Kim, Sinae Kim, Eun Ji Lee, Min Ji Park, Jae-Weon Kim, Byoung-Gie Kim, Eun-Hae Cho, Suhwan Chang,[...]. Cancer Res 2022
0

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing.
Loïck Galland, Elise Ballot, Hugo Mananet, Romain Boidot, Julie Lecuelle, Juliette Albuisson, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai,[...]. NPJ Breast Cancer 2022
0

Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor Recurrence.
Chia-Hsin Wu, Hsien-Tang Yeh, Chia-Shan Hsieh, Chi-Cheng Huang, Amrita Chattopadhyay, Yuan-Chiang Chung, Shih-Hsin Tu, Yung-Hua Li, Tzu-Pin Lu, Liang-Chuan Lai,[...]. Cancers (Basel) 2021
0

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses.
Pei Sze Ng, Jia Wern Pan, Muhammad Mamduh Ahmad Zabidi, Pathmanathan Rajadurai, Cheng Har Yip, Oscar M Reuda, Alison M Dunning, Antonis C Antoniou, Douglas F Easton, Carlos Caldas,[...]. NPJ Breast Cancer 2021
2



MutScape: an analytical toolkit for probing the mutational landscape in cancer genomics.
Cheng-Hua Lu, Chia-Hsin Wu, Mong-Hsun Tsai, Liang-Chuan Lai, Eric Y Chuang. NAR Genom Bioinform 2021
0

Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations.
Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Judit Borcsok, Mark M Pomerantz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, István Csabai, Matthew L Freedman,[...]. Clin Cancer Res 2020
32

Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes.
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, Li-Xuan Qin, Ping Chi, Mark Dickson, Mrinal Gounder, Ciara Kelly, Mary L Keohan, Benjamin Nacev,[...]. JCO Precis Oncol 2020
10

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
E Rempel, K Kluck, S Beck, I Ourailidis, D Kazdal, O Neumann, A L Volckmar, M Kirchner, H Goldschmid, N Pfarr,[...]. NPJ Precis Oncol 2022
0

Biomarkers for Homologous Recombination Deficiency in Cancer.
Svenja Wagener-Ryczek, Sabine Merkelbach-Bruse, Janna Siemanowski. J Pers Med 2021
6